Clinical trial
Prognostic Value of Examined and Metastatic Lymph Nodes in Chinese Esophageal Squamous Cell Carcinoma Patients Received Lymphadenectomy
NCT04764240 is registered in ClinicalTrials.gov with Shanghai Cancer Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of Examined and Metastatic Lymph Nodes in Chinese Esophageal Squamous Cell Carcinoma Patients Received Lymphadenectomy
- Lead sponsor
- Shanghai Cancer Hospital, China
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2003
- Completion date
- December 31, 2018
- Enrollment
- 3,700 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.